Table 3. Viral and bacterial targets detected, by age group, among patients who took an influenza A and B virus and RSV point-of-care test at a hospital emergency department, Capital Region of Denmark, February–July 2018 (n = 312).
| Pathogen detected | Age (years) | ||||
|---|---|---|---|---|---|
| 0–1 | 2–5 | 6–17 | 18–65 | > 65 | |
| Bordetella pertussis | 1 | 0 | 0 | 0 | 0 |
| Enterovirus | 13 | 2 | 1 | 1 | 0 |
| Human coronavirus 229E | 1 | 0 | 0 | 0 | 1 |
| Human coronavirus HKU1 | 0 | 0 | 0 | 2 | 0 |
| Human coronavirus NL63 | 6 | 0 | 2 | 2 | 0 |
| Human coronavirus OC43 | 0 | 0 | 0 | 1 | 0 |
| Human mastadenovirus A-G | 15 | 5 | 2 | 6 | 1 |
| Human metapneumovirus | 7 | 2 | 0 | 12 | 10 |
| RSV | 30 | 1 | 0 | 8 | 10 |
| Human polyomavirus 3 | 1 | 1 | 0 | 0 | 0 |
| Human polyomavirus 4 | 5 | 1 | 0 | 0 | 0 |
| Human respirovirus 1 | 1 | 0 | 0 | 0 | 0 |
| Human respirovirus 3 | 10 | 2 | 0 | 3 | 2 |
| Influenza A virus (non-typeable) | 1 | 0 | 1 | 4 | 1 |
| Influenza A(H1N1)pdm09 virus | 3 | 4 | 1 | 9 | 2 |
| Influenza A(H3N2) virus | 1 | 1 | 3 | 13 | 15 |
| Influenza B virus | 1 | 1 | 1 | 26 | 28 |
| Mycoplasma pneumoniae | 0 | 0 | 1 | 6 | 0 |
| Parechovirus | 1 | 0 | 0 | 0 | 0 |
| Primate bocaparvovirus 1 + 2 | 3 | 0 | 0 | 1 | 0 |
| Rhinovirus | 36 | 2 | 3 | 12 | 8 |
| Total number of detected viruses | 135 | 22 | 14 | 100 | 78 |
| Total number of detected bacteria | 1 | 0 | 1 | 6 | 0 |
| Total number of samples with detection of one pathogen | 74 | 15 | 13 | 98 | 76 |
| Total number of samples with co-detection of pathogens | 28 | 2 | 1 | 4 | 1 |
| Total number of samples tested negative for all pathogens | 20 | 12 | 15 | 108 | 88 |
| Single target detection rate % | 60.7 | 51.7 | 44.8 | 46.7 | 46.1 |
| Coinfection rate % | 23.0 | 6.9 | 3.4 | 1.9 | 0.6 |
RSV: respiratory syncytial virus.
All samples were negative for Bordetella parapertussis, Chlamydia pneumoniae, Chlamydia psittaci, human orthorubulavirus 2 and 4, influenza C virus and Legionella spp.